BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 5, 2010
View Archived Issues
Interim results from phase I study on anti-ALK-1 mAb PF-03446962 in solid tumors presented
Read More
Preliminary phase I data on HDAC inhibitor CHR-3996 in advanced solid tumors disclosed
Read More
Banyu discovers Wee1 kinase inhibitors for cancer therapy
Read More
Janssen claims new fatty acid amide hydrolase inhibitors
Read More
AstraZeneca presents new antimycobacterial agents
Read More
Euroscreen claims new GPR43 agonists/partial agonists
Read More
Novel DDAH inhibitors disclosed by German scientists
Read More
GPR119 agonist AS-1535907 regulates insulin expression and pancreatic beta-cell mass in vivo
Read More
CRASH-2 findings support use of tranexamic acid in trauma patients with significant bleeding
Read More
Genetic profiles of patients responding to antihypertensive rostafuroxine identified
Read More
InNexus develops protein for potential use in AMD
Read More
Sangamo receives funding to develop Parkinson's disease treatment
Read More
Phosphagenics to assess dosing regimen for its transdermal oxycodone patch
Read More
GSK and Genmab amend ofatumumab agreement
Read More
Evotec starts phase II study of EVT-101 in treatment-resistant depression
Read More
FDA grants Cyclacel orphan designation for sapacitabine in AML and MDS
Read More
Final data from Zadaxin study show enhanced immune response after vaccination
Read More
Oxygen reports porcine animal model results for Oxycyte in decompression sickness
Read More
Sanofi-aventis and JDRF partner for type 1 diabetes therapeutics
Read More
MorphoSys achieves milestone in antibody partnership with Novartis
Read More
Phase III study of Avastin combined with chemotherapy meets primary endpoint
Read More
Javelin to become fully owned subsidiary of Hospira
Read More
Intercell reports results from phase II trial of Vaccine Enhancement Patch
Read More
Lilly set to acquire Alnara and its PERT therapy liprotamase
Read More
Otsuka and MethylGene extend collaboration for kinase inhibitors in ocular diseases
Read More